Recursion is a Salt Lake City biotech company that uses AI to find and develop medicines for cancer and rare diseases. RXRX reports earnings on Mon, Nov 2, 2026. In the past 30 days there were 14 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 25 | Leerink Partners | Maintained | Hold |
Whale Options Flow
90DNo whale options trades in RXRX in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RXRX is in one of them and how their past RXRX trades turned out.
RXRX News Tone and Price
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered RXRX in an article yet. Here's the latest on the wider market.
About Recursion Pharmaceuticals
Recursion is a biotechnology company based in Salt Lake City, Utah, that uses artificial intelligence to discover and develop medicines. Its work centers on the Recursion Operating System, a platform that combines biological data, computational molecule design and clinical trial planning. The company develops its own drug candidates, mainly for cancer and rare diseases, and partners with drugmakers such as Roche, Genentech and Sanofi on discovery programs. Its medicines are aimed at patients with serious diseases that have limited treatment options.
- Headquarters
- Salt Lake City, UT